Your browser doesn't support javascript.
loading
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
Sportoletti, Paolo; Laurenti, Luca; Chiarenza, Annalisa; Gaidano, Gianluca; Albi, Elisa; Mauro, Francesca Romana; Trentin, Livio; Vallisa, Daniele; Pane, Fabrizio; Cuneo, Antonio; Albano, Francesco; Zamprogna, Giulia; Coscia, Marta; Gozzetti, Alessandro; Reda, Gianluigi; Caira, Morena; Finsinger, Paola; Gualberti, Giuliana; Iannella, Emilia; Malgieri, Simona; Molica, Stefano.
Afiliação
  • Sportoletti P; Institute of Hematology and Center for Hemato-Oncology Research, University of Perugia and Santa Maria della Misericordia Hospital, Perugia, Italy.
  • Laurenti L; Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
  • Chiarenza A; Division of Hematology, Ferrarotto Hospital, Catania, Italy.
  • Gaidano G; Division of Haematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
  • Albi E; Strategic Research Programme in CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
  • Mauro FR; Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
  • Trentin L; Hematology Section, Department of Medicine, Azienda Ospedale Università Padova, Padova, Italy.
  • Vallisa D; Hematology Unit, Department of Oncology and Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
  • Pane F; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Cuneo A; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Albano F; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Hematology and Stem Cell Transplantation Unit, University of Bari "Aldo Moro", Bari, Italy.
  • Zamprogna G; Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Coscia M; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Gozzetti A; Hematology, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Reda G; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore, University of Milan, Milan, Italy.
  • Caira M; AbbVie S.r.l., Campoverde, Latina, Italy.
  • Finsinger P; AbbVie S.r.l., Campoverde, Latina, Italy.
  • Gualberti G; AbbVie S.r.l., Campoverde, Latina, Italy.
  • Iannella E; AbbVie S.r.l., Campoverde, Latina, Italy.
  • Malgieri S; AbbVie S.r.l., Campoverde, Latina, Italy.
  • Molica S; Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
Hematol Oncol ; 42(1): e3216, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37772620
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article